These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 2998642

  • 1. AH23848: a thromboxane receptor-blocking drug that can clarify the pathophysiologic role of thromboxane A2.
    Brittain RT, Boutal L, Carter MC, Coleman RA, Collington EW, Geisow HP, Hallett P, Hornby EJ, Humphrey PP, Jack D.
    Circulation; 1985 Dec; 72(6):1208-18. PubMed ID: 2998642
    [Abstract] [Full Text] [Related]

  • 2. GR32191, a highly potent and specific thromboxane A2 receptor blocking drug on platelets and vascular and airways smooth muscle in vitro.
    Lumley P, White BP, Humphrey PP.
    Br J Pharmacol; 1989 Jul; 97(3):783-94. PubMed ID: 2527074
    [Abstract] [Full Text] [Related]

  • 3. Pathophysiological actions of thromboxane A2 and their pharmacological antagonism by thromboxane receptor blockade with GR32191.
    Humphrey PP, Hallet P, Hornby EJ, Wallis CJ, Collington EW, Lumley P.
    Circulation; 1990 Jan; 81(1 Suppl):I42-52; discussion I59-60. PubMed ID: 2136817
    [Abstract] [Full Text] [Related]

  • 4. Effect of the specific thromboxane receptor blocking drug AH23848 in patients with angina pectoris.
    De Bono DP, Lumley P, Been M, Keery R, Ince SE, Woodings DF.
    Br Heart J; 1986 Dec; 56(6):509-17. PubMed ID: 2948534
    [Abstract] [Full Text] [Related]

  • 5. Novel angiotensin II AT(1) receptor antagonist irbesartan prevents thromboxane A(2)-induced vasoconstriction in canine coronary arteries and human platelet aggregation.
    Li P, Fukuhara M, Diz DI, Ferrario CM, Brosnihan KB.
    J Pharmacol Exp Ther; 2000 Jan; 292(1):238-46. PubMed ID: 10604953
    [Abstract] [Full Text] [Related]

  • 6. Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human platelets.
    Watts IS, Wharton KA, White BP, Lumley P.
    Br J Pharmacol; 1991 Feb; 102(2):497-505. PubMed ID: 1826620
    [Abstract] [Full Text] [Related]

  • 7. Coronary vascular occlusion mediated via thromboxane A2-prostaglandin endoperoxide receptor activation in vivo.
    Fitzgerald DJ, Doran J, Jackson E, FitzGerald GA.
    J Clin Invest; 1986 Feb; 77(2):496-502. PubMed ID: 3003161
    [Abstract] [Full Text] [Related]

  • 8. ZD1542, a potent thromboxane A2 synthase inhibitor and receptor antagonist in vitro.
    Brownlie RP, Brownrigg NJ, Butcher HM, Garcia R, Jessup R, Lee VJ, Tunstall S, Wayne MG.
    Br J Pharmacol; 1993 Dec; 110(4):1600-6. PubMed ID: 8306107
    [Abstract] [Full Text] [Related]

  • 9. Heterogeneity of prostaglandin H2/thromboxane A2 receptors: distinct subtypes mediate vascular smooth muscle contraction and platelet aggregation.
    Furci L, Fitzgerald DJ, Fitzgerald GA.
    J Pharmacol Exp Ther; 1991 Jul 01; 258(1):74-81. PubMed ID: 1830100
    [Abstract] [Full Text] [Related]

  • 10. Preliminary clinical studies with thromboxane synthase inhibitors and thromboxane receptor blockers. A review.
    Fiddler GI, Lumley P.
    Circulation; 1990 Jan 01; 81(1 Suppl):I69-78; discussion I79-80. PubMed ID: 2136820
    [Abstract] [Full Text] [Related]

  • 11. 7-Oxabicyclo[2.2.1]heptane analogs as modulators of the thromboxane A2 and prostacyclin receptors.
    Sprague PW, Heikes JE, Harris DN, Greenberg R.
    Adv Prostaglandin Thromboxane Leukot Res; 1983 Jan 01; 11():337-43. PubMed ID: 6303073
    [No Abstract] [Full Text] [Related]

  • 12. Interspecies differences in thromboxane receptors: studies with thromboxane receptor antagonists in rat and guinea pig smooth muscles.
    Ogletree ML, Allen GT.
    J Pharmacol Exp Ther; 1992 Feb 01; 260(2):789-94. PubMed ID: 1531361
    [Abstract] [Full Text] [Related]

  • 13. A comparative study of the involvement of the prostaglandin H2/thromboxane A2 pathway in intravascular platelet aggregation in guinea-pigs and rats.
    Mallarkey G, Smith GM.
    Br J Pharmacol; 1985 Feb 01; 84(2):425-30. PubMed ID: 3156648
    [Abstract] [Full Text] [Related]

  • 14. Inhibitory effect of a selective thromboxane A2 receptor antagonist, EP 092, on platelet aggregation in whole blood ex vivo and in vivo.
    Booth RF, Honey AC, Lad N, Tuffin DP, Wade PJ.
    Br J Pharmacol; 1989 Feb 01; 96(2):395-405. PubMed ID: 2522336
    [Abstract] [Full Text] [Related]

  • 15. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
    Yu SM, Wu TS, Teng CM.
    Br J Pharmacol; 1994 Mar 01; 111(3):906-12. PubMed ID: 8019768
    [Abstract] [Full Text] [Related]

  • 16. Antagonism of prostaglandin-mediated responses in platelets and vascular smooth muscle by 13-azaprostanoic acid analogs. Evidence for selective blockade of thromboxane A2 responses.
    Huzoor-Akbar, Mukhopadhyay A, Anderson KS, Navran SS, Romstedt K, Miller DD, Feller DR.
    Biochem Pharmacol; 1985 Mar 01; 34(5):641-7. PubMed ID: 3156599
    [Abstract] [Full Text] [Related]

  • 17. A specific thromboxane receptor blocking drug, AH23848, reduces platelet deposition on vascular grafts in man.
    Lane IF, Lumley P, Michael MF, Peters AM, McCollum CN.
    Thromb Haemost; 1990 Nov 30; 64(3):369-73. PubMed ID: 2151407
    [Abstract] [Full Text] [Related]

  • 18. Antihypertensive effect of thromboxane A2 receptor blockade in genetically hypertensive rats of the Lyon strain.
    Geoffroy J, Benzoni D, Sassard J.
    J Hypertens Suppl; 1989 Dec 30; 7(6):S272-3. PubMed ID: 2534414
    [Abstract] [Full Text] [Related]

  • 19. Endogenous prostaglandin endoperoxides and prostacyclin modulate the thrombolytic activity of tissue plasminogen activator. Effects of simultaneous inhibition of thromboxane A2 synthase and blockade of thromboxane A2/prostaglandin H2 receptors in a canine model of coronary thrombosis.
    Golino P, Rosolowsky M, Yao SK, McNatt J, De Clerck F, Buja LM, Willerson JT.
    J Clin Invest; 1990 Oct 30; 86(4):1095-102. PubMed ID: 2145320
    [Abstract] [Full Text] [Related]

  • 20. Characterization of contraction-mediating prostanoid receptors in human hand veins: effects of the thromboxane receptor antagonists BM13,505 and AH23848.
    Arner M, Högestätt ED, Uski TK.
    Acta Physiol Scand; 1991 Jan 30; 141(1):79-86. PubMed ID: 2053448
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.